Hemoglobinopathy is a genetic disorder that causes abnormal production or aberration in the hemoglobin structure. Hemoglobinopathies are the most common type of Sickle Cell disease and are hereditary. The formation of the abnormal hemoglobin is observed due to structural defects in the hemoglobin molecule, diminished production of one of the two subunits of the hemoglobin molecule and abnormal associations of otherwise normal subunits. Hemoglobinopathies are formed due to defects in genes and anemia.
The market is driven by rising cases of hemoglobin disorders such as sickle cell disease, thalassemia, Hb C, and Hb E, increase in R&D activities to develop new therapeutics, increase in awareness program by government and robust pipeline. Insufficient healthcare infrastructure, no permanent cure, and lack of skilled professionals to interpret the complex data are going to restrain the market in the forecast period.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: